These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ý
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
52-2107911
|
|
(State of incorporation)
|
(I.R.S. Employer Identification No.)
|
|
Large accelerated filer
|
ý
|
Accelerated filer
|
o
|
|
|
Non-accelerated filer
|
o
|
Smaller reporting company
|
o
|
|
Page
|
||
|
|
||
|
Item 1.
|
Financial Statements:
|
|
|
Consolidated Condensed Balance Sheets at September 30, 2011 and December 31, 2010 (Unaudited)
|
4
|
|
|
Consolidated Condensed Statements of Operations for the Three and Nine Months Ended September 30, 2011 and 2010 (Unaudited)
|
5
|
|
|
Consolidated Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2011 and 2010 (Unaudited)
|
6
|
|
|
Notes to Consolidated Condensed Financial Statements (Unaudited)
|
7
|
|
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
24
|
|
Item 3.
|
Quantitative and Qualitative Disclosures about Market Risk
|
57
|
|
Item 4.
|
Controls and Procedures
|
58
|
|
|
||
|
Item 1.
|
Legal Proceedings
|
59
|
|
Item 1A.
|
Risk Factors
|
59
|
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of
Proceeds
|
72
|
|
Item 6.
|
Exhibits
|
72
|
|
Signatures
|
73
|
|
|
Exhibit
Index
|
74
|
|
|
September 30,
2011
|
December 31,
2010
|
|||||||
|
ASSETS
|
||||||||
|
Current Assets
|
||||||||
|
Cash and cash equivalents
|
$ | 117.9 | $ | 151.0 | ||||
|
Accounts receivable, net
|
223.5 | 308.6 | ||||||
|
Inventories
|
1,721.5 | 1,522.5 | ||||||
|
Deferred income taxes
|
24.0 | 47.5 | ||||||
|
Deferred costs associated with deferred revenue
|
159.8 | 152.9 | ||||||
|
Other current assets
|
88.0 | 71.6 | ||||||
|
Total Current Assets
|
2,334.7 | 2,254.1 | ||||||
|
Property, Plant and Equipment, net
|
1,321.4 | 1,231.4 | ||||||
|
Other Long-Term Assets
|
||||||||
|
Deferred income taxes
|
222.1 | 204.5 | ||||||
|
Deposits for surety bonds
|
144.4 | 140.8 | ||||||
|
Deferred financing costs, net
|
12.8 | 10.6 | ||||||
|
Goodwill
|
6.8 | 6.8 | ||||||
|
Total Other Long-Term Assets
|
386.1 | 362.7 | ||||||
|
Total Assets
|
$ | 4,042.2 | $ | 3,848.2 | ||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
|
Current Liabilities
|
||||||||
|
Accounts payable and accrued liabilities
|
$ | 153.0 | $ | 172.4 | ||||
|
Payables under Russian Contract
|
284.8 | 201.2 | ||||||
|
Inventories owed to customers and suppliers
|
843.2 | 715.8 | ||||||
|
Deferred revenue and advances from customers
|
192.1 | 179.1 | ||||||
|
Credit facility term loan
|
85.0 | - | ||||||
|
Total Current Liabilities
|
1,558.1 | 1,268.5 | ||||||
|
Long-Term Debt
|
530.0 | 660.0 | ||||||
|
Convertible Preferred Stock
|
85.9 | 78.2 | ||||||
|
Other Long-Term Liabilities
|
||||||||
|
Depleted uranium disposition
|
139.7 | 125.4 | ||||||
|
Postretirement health and life benefit obligations
|
185.4 | 178.7 | ||||||
|
Pension benefit liabilities
|
143.0 | 145.4 | ||||||
|
Other liabilities
|
78.0 | 78.2 | ||||||
|
Total Other Long-Term Liabilities
|
546.1 | 527.7 | ||||||
|
Commitments and Contingencies (Note 12)
|
||||||||
|
Stockholders’ Equity
|
1,322.1 | 1,313.8 | ||||||
|
Total Liabilities and Stockholders’ Equity
|
$ | 4,042.2 | $ | 3,848.2 | ||||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2011
|
2010
|
2011
|
2010
|
|||||||||||||
|
Revenue:
|
||||||||||||||||
|
Separative work units
|
$ | 297.9 | $ | 404.2 | $ | 936.7 | $ | 1,001.8 | ||||||||
|
Uranium
|
21.3 | 79.3 | 103.1 | 164.5 | ||||||||||||
|
Contract services
|
55.3 | 81.1 | 169.6 | 202.7 | ||||||||||||
|
Total Revenue
|
374.5 | 564.6 | 1,209.4 | 1,369.0 | ||||||||||||
|
Cost of Sales:
|
||||||||||||||||
|
Separative work units and uranium
|
298.5 | 451.4 | 974.3 | 1,077.2 | ||||||||||||
|
Contract services
|
49.1 | 75.2 | 161.1 | 183.0 | ||||||||||||
|
Total Cost of Sales
|
347.6 | 526.6 | 1,135.4 | 1,260.2 | ||||||||||||
|
Gross profit
|
26.9 | 38.0 | 74.0 | 108.8 | ||||||||||||
|
Advanced technology costs
|
26.0 | 28.6 | 86.2 | 80.3 | ||||||||||||
|
Selling, general and administrative
|
15.6 | 14.0 | 47.8 | 43.4 | ||||||||||||
|
Other (income)
|
- | (12.4 | ) | (3.7 | ) | (32.4 | ) | |||||||||
|
Operating income (loss)
|
(14.7 | ) | 7.8 | (56.3 | ) | 17.5 | ||||||||||
|
Preferred stock issuance costs
|
- | 4.8 | - | 4.8 | ||||||||||||
|
Interest expense
|
0.2 | 0.3 | 0.3 | 0.4 | ||||||||||||
|
Interest (income)
|
(0.1 | ) | (0.2 | ) | (0.4 | ) | (0.4 | ) | ||||||||
|
Income (loss) before income taxes
|
(14.8 | ) | 2.9 | (56.2 | ) | 12.7 | ||||||||||
|
Provision (benefit) for income taxes
|
(7.9 | ) | 1.9 | (11.5 | ) | 14.2 | ||||||||||
|
Net income (loss)
|
$ | (6.9 | ) | $ | 1.0 | $ | (44.7 | ) | $ | (1.5 | ) | |||||
|
Net income (loss) per share – basic
|
$ | (.06 | ) | $ | .01 | $ | (.37 | ) | $ | (.01 | ) | |||||
|
Net income (loss) per share – diluted
|
$ | (.06 | ) | $ | .01 | $ | (.37 | ) | $ | (.01 | ) | |||||
|
Weighted-average number of shares outstanding:
|
||||||||||||||||
|
Basic
|
121.3 | 113.2 | 120.7 | 112.6 | ||||||||||||
|
Diluted
|
121.3 | 166.4 | 120.7 | 112.6 | ||||||||||||
|
Nine Months Ended
September 30,
|
||||||||
|
2011
|
2010
|
|||||||
|
Cash Flows from Operating Activities
|
||||||||
|
Net (loss)
|
$ | (44.7 | ) | $ | (1.5 | ) | ||
|
Adjustments to reconcile net (loss) to net cash provided byoperating activities:
|
||||||||
|
Depreciation and amortization
|
40.6 | 30.2 | ||||||
|
Deferred income taxes
|
2.2 | 31.9 | ||||||
|
Other non-cash income on release of disposal obligation
|
(0.6 | ) | (32.4 | ) | ||||
|
Preferred stock issuance costs and capitalized dividends paid-in-kind
|
7.7 | 5.6 | ||||||
|
Gain on extinguishment of convertible senior notes
|
(3.1 | ) | - | |||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable – decrease (increase)
|
85.1 | (36.6 | ) | |||||
|
Inventories, net – (increase)
|
(71.6 | ) | (53.9 | ) | ||||
|
Payables under Russian Contract – increase
|
83.6 | 96.6 | ||||||
|
Deferred revenue, net of deferred costs – increase
|
6.5 | 4.1 | ||||||
|
Accrued depleted uranium disposition – increase (decrease)
|
14.3 | (36.4 | ) | |||||
|
Accounts payable and other liabilities – (decrease) increase
|
(0.1 | ) | 8.5 | |||||
|
Other, net
|
(12.7 | ) | 13.9 | |||||
|
Net Cash Provided by Operating Activities
|
107.2 | 30.0 | ||||||
|
Cash Flows Used in Investing Activities
|
||||||||
|
Capital expenditures
|
(130.3 | ) | (123.0 | ) | ||||
|
Deposits for surety bonds – net (increase) decrease
|
(3.6 | ) | 48.1 | |||||
|
Net Cash (Used in) Investing Activities
|
(133.9 | ) | (74.9 | ) | ||||
|
Cash Flows Used in Financing Activities
|
||||||||
|
Borrowings under revolving credit facility
|
- | 38.3 | ||||||
|
Repayments under revolving credit facility
|
- | (38.3 | ) | |||||
|
Proceeds from issuance of Series B-1 convertible preferred stock and warrants
|
- | 75.0 | ||||||
|
Payments for deferred financing costs and preferred stock issuance costs
|
(4.7 | ) | (13.2 | ) | ||||
|
Common stock issued (purchased), net
|
(1.7 | ) | (2.1 | ) | ||||
|
Net Cash Provided by (Used in) Financing Activities
|
(6.4 | ) | 59.7 | |||||
|
Net (Decrease) Increase
|
(33.1 | ) | 14.8 | |||||
|
Cash and Cash Equivalents at Beginning of Period
|
151.0 | 131.3 | ||||||
|
Cash and Cash Equivalents at End of Period
|
$ | 117.9 | $ | 146.1 | ||||
|
Supplemental Cash Flow Information:
|
||||||||
|
Interest paid, net of amount capitalized
|
$ | - | $ | - | ||||
|
Income taxes paid, net of refunds
|
2.3 | 2.7 | ||||||
|
September 30,
2011
|
December 31,
2010
|
|||||||
|
Current assets:
|
||||||||
|
Separative work units
|
$ | 1,020.6 | $ | 947.4 | ||||
|
Uranium
|
687.8 | 562.5 | ||||||
|
Materials and supplies
|
13.1 | 12.6 | ||||||
| 1,721.5 | 1,522.5 | |||||||
|
Current liabilities:
|
||||||||
|
Inventories owed to customers and suppliers
|
(843.2 | ) | (715.8 | ) | ||||
|
Inventories, net
|
$ | 878.3 | $ | 806.7 | ||||
|
December 31,
2010
|
Capital Expenditures
(Depreciation
)
|
Transfers
and
Retirements
|
September 30,
2011
|
|||||||||||||
|
Construction work in progress
|
$ | 1,126.3 | $ | 134.8 | $ | (21.5 | ) | $ | 1,239.6 | |||||||
|
Leasehold improvements
|
187.3 | - | 4.0 | 191.3 | ||||||||||||
|
Machinery and equipment
|
269.1 | - | (2.5 | ) | 266.6 | |||||||||||
| 1,582.7 | 134.8 | (20.0 | ) | 1,697.5 | ||||||||||||
|
Accumulated depreciation and amortization
|
(351.3 | ) | (35.0 | ) | 10.2 | (376.1 | ) | |||||||||
| $ | 1,231.4 | $ | 99.8 | $ | (9.8 | ) | $ | 1,321.4 | ||||||||
|
September 30,
2011
|
December 31,
2010
|
|||||||
|
(millions)
|
||||||||
|
Deferred revenue
|
$ | 166.1 | $ | 176.1 | ||||
|
Advances from customers
|
26.0 | 3.0 | ||||||
| $ | 192.1 | $ | 179.1 | |||||
|
Deferred costs associated with deferred revenue
|
$ | 159.8 | $ | 152.9 | ||||
|
September 30,
|
December 31,
|
|||||||
|
2011
|
2010
|
|||||||
|
(millions)
|
||||||||
|
Borrowings under the revolving credit facility
|
$ | - | $ | - | ||||
|
Term loan
|
85.0 | 85.0 | ||||||
|
Letters of credit
|
16.9 | 17.3 | ||||||
|
Available credit
|
208.1 | 207.7 | ||||||
|
•
|
Level 1 – quoted prices in active markets for identical assets or liabilities.
|
|
•
|
Level 2 – inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.
|
|
•
|
Level 3 – unobservable inputs in which little or no market data exists.
|
|
Fair Value Measurements
(in millions)
|
||||||||||||||||||||||||||||||||
|
September 30, 2011
|
December 31, 2010
|
|||||||||||||||||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||||||||||||||
|
Assets:
|
||||||||||||||||||||||||||||||||
|
Deferred compensation asset (a)
|
- | $ | 2.1 | - | $ | 2.1 | - | $ | 1.8 | - | $ | 1.8 | ||||||||||||||||||||
|
Liabilities:
|
||||||||||||||||||||||||||||||||
|
Deferred compensation obligation (a)
|
- | 2.3 | - | 2.3 | - | 2.0 | - | 2.0 | ||||||||||||||||||||||||
|
Convertible preferred stock (b)
|
- | - | 85.9 | 85.9 | - | - | 78.2 | 78.2 | ||||||||||||||||||||||||
|
(a)
The deferred compensation obligation represents the balance of deferred compensation plus net investment earnings. The deferred compensation plan is informally funded through a rabbi trust using variable universal life insurance. The cash surrender value of the life insurance policies is designed to track the deemed investments of the plan participants. Investment crediting options consist of institutional and retail investment funds. The deemed investments are classified within Level 2 of the valuation hierarchy because (i) of the indirect method of investing and (ii) unit prices of institutional
funds are not quoted in active markets; however, the unit prices are based on the underlying investments which are traded in active markets.
|
|
(b)
The estimated fair value of the convertible preferred stock is based on a market approach using a discount rate of 12.75%, which is unobservable (Level 3) since the instruments do not trade. Dividends on the convertible preferred stock are paid as additional shares of convertible preferred stock on a quarterly basis at an annual rate of 12.75%, which is consistent with current market prices and other market benchmarks. The estimated fair value equals the liquidation value of $1,000 per share.
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2011
|
2010
|
2011
|
2010
|
|||||||||||||
|
Convertible preferred stock:
|
||||||||||||||||
|
Beginning balance
|
$ | 83.3 | $ | - | $ | 78.2 | $ | - | ||||||||
|
Less: paid-in-kind dividends payable, beginning balance
|
(2.6 | ) | - | (2.4 | ) | - | ||||||||||
|
Issuances
|
2.6 | 75.0 | 7.5 | 75.0 | ||||||||||||
|
Paid-in-kind dividends payable
|
2.6 | 0.8 | 2.6 | 0.8 | ||||||||||||
|
Total gains or losses (realized/unrealized)
|
- | - | - | - | ||||||||||||
|
Ending balance
|
$ | 85.9 | $ | 75.8 | $ | 85.9 | $ | 75.8 | ||||||||
|
September 30, 2011
|
December 31, 2010
|
|||||||||||||||
|
Carrying
Value
|
Fair
Value
|
Carrying
Value
|
Fair
Value
|
|||||||||||||
|
Credit facility term loan, due May 31, 2012
|
$ | 85.0 | $ | 74.4 | $ | 85.0 | $ | 85.6 | ||||||||
|
3.0% convertible senior notes, due October 1, 2014
|
530.0 | 278.3 | 575.0 | 517.9 | ||||||||||||
|
|
Defined Benefit Pension Plans
|
Postretirement Health and Life Benefits Plans
|
||||||||||||||||||||||||||||||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||||||||||||||||
|
2011
|
2010
|
2011
|
2010
|
2011
|
2010
|
2011
|
2010
|
|||||||||||||||||||||||||
|
Service costs
|
$ | 4.0 | $ | 4.8 | $ | 12.0 | $ | 14.5 | $ | 0.7 | $ | 1.2 | $ | 3.4 | $ | 3.7 | ||||||||||||||||
|
Interest costs
|
12.6 | 12.3 | 37.7 | 36.7 | 2.9 | 3.0 | 9.0 | 8.9 | ||||||||||||||||||||||||
|
Expected return on plan assets
(gains)
|
(13.5 | ) | (12.2 | ) | (40.4 | ) | (36.6 | ) | (1.0 | ) | (0.9 | ) | (2.8 | ) | (2.7 | ) | ||||||||||||||||
|
Amortization of prior service costs
(credits)
|
0.4 | 0.4 | 1.2 | 1.3 | - | (2.1 | ) | - | (6.3 | ) | ||||||||||||||||||||||
|
Amortization of actuarial losses
|
2.2 | 4.0 | 6.9 | 12.0 | 0.7 | 0.7 | 2.0 | 2.0 | ||||||||||||||||||||||||
|
Curtailment losses
|
- | - | 3.2 | - | - | - | 1.9 | - | ||||||||||||||||||||||||
|
Net benefit costs
|
$ | 5.7 | $ | 9.3 | $ | 20.6 | $ | 27.9 | $ | 3.3 | $ | 1.9 | $ | 13.5 | $ | 5.6 | ||||||||||||||||
|
Common Stock,
Par Value
$.10 per Share
|
Excess of
Capital over
Par Value
|
Retained
Earnings
|
Treasury
Stock
|
Accumulated
Other Comprehensive
Income (Loss)
|
Total
|
|||||||||||||||||||
|
Nine Months Ended September 30, 2010
|
||||||||||||||||||||||||
|
Balance at December 31, 2009
|
$ | 12.3 | $ | 1,179.6 | $ | 322.4 | $ | (71.3 | ) | $ | (167.4 | ) | $ | 1,275.6 | ||||||||||
|
Amortization of actuarial losses and prior service costs (credits), net of income tax of $3.0 million
|
- | - | - | - | 6.0 | 6.0 | ||||||||||||||||||
|
Net (loss)
|
- | - | (1.5 | ) | - | - | (1.5 | ) | ||||||||||||||||
|
Comprehensive (loss)
|
4.5 | |||||||||||||||||||||||
|
Restricted and other common stock issued, net of amortization
|
- | (8.3 | ) | - | 13.8 | - | 5.5 | |||||||||||||||||
|
Balance at September 30, 2010
|
$ | 12.3 | $ | 1,171.3 | $ | 320.9 | $ | (57.5 | ) | $ | (161.4 | ) | $ | 1,285.6 | ||||||||||
|
Nine Months Ended September 30, 2011
|
||||||||||||||||||||||||
|
Balance at December 31, 2010
|
$ | 12.3 | $ | 1,172.8 | $ | 329.9 | $ | (57.1 | ) | $ | (144.1 | ) | $ | 1,313.8 | ||||||||||
|
Amortization of actuarial losses and prior service costs (credits), net of income tax of $3.7 million
|
- | - | - | - | 6.4 | 6.4 | ||||||||||||||||||
|
Net (loss)
|
- | - | (44.7 | ) | - | - | (44.7 | ) | ||||||||||||||||
|
Comprehensive (loss)
|
(38.3 | ) | ||||||||||||||||||||||
|
Common stock issued in exchange for convertible senior notes
|
0.7 | 40.5 | - | - | - | 41.2 | ||||||||||||||||||
|
Restricted and other common stock issued, net of amortization
|
- | (1.1 | ) | - | 6.5 | - | 5.4 | |||||||||||||||||
|
Balance at September 30, 2011
|
$ | 13.0 | $ | 1,212.2 | $ | 285.2 | $ | (50.6 | ) | $ | (137.7 | ) | $ | 1,322.1 | ||||||||||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2011
|
2010
|
2011
|
2010
|
|||||||||||||
|
Total stock-based compensation costs (millions):
|
||||||||||||||||
|
Restricted stock and restricted stock units
|
$ | 1.6 | $ | 1.3 | $ | 6.0 | $ | 6.2 | ||||||||
|
Stock options, performance awards and other
|
0.3 | 0.4 | 1.1 | 1.5 | ||||||||||||
|
Less: costs capitalized as part of inventory
|
- | (0.1 | ) | (0.4 | ) | (0.3 | ) | |||||||||
|
Expense included in selling, general and administrative and advanced technology costs
|
$ | 1.9 | $ | 1.6 | $ | 6.7 | $ | 7.4 | ||||||||
|
Total after-tax expense
|
$ | 1.2 | $ | 1.1 | $ | 4.3 | $ | 4.8 | ||||||||
|
Additional information:
|
||||||||||||||||
|
Stock options exercised
|
- | 92,754 | - | 115,630 | ||||||||||||
|
Intrinsic value of stock options exercised (millions)
|
- | $ | 0.1 | - | $ | 0.2 | ||||||||||
|
Cash received from exercise of stock options (millions)
|
- | $ | 0.4 | - | $ | 0.5 | ||||||||||
|
Three Months Ended S
eptember 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||||||||||
|
2011
|
2010
|
2011
|
2010
|
|||||||||||||||||||||
|
Risk-free interest rate
|
- | 0.78 | % | - | 0.78 | – | 1.43 | % | ||||||||||||||||
|
Expected dividend yield
|
- | - | - | - | ||||||||||||||||||||
|
Expected volatility
|
- | 75 | % | - | 72 | – | 75 | % | ||||||||||||||||
|
Expected option life (years)
|
- | 4.1 | - | 4 | – | 4.1 | ||||||||||||||||||
|
Weighted-average grant date fair value
|
- | $ | 3.09 | - | $ | 2.81 | ||||||||||||||||||
|
Options granted
|
0 | 6,968 | 0 | 773,018 | ||||||||||||||||||||
|
·
|
Total stock return volatility based on historical volatility over one year using daily stock price observations,
|
|
·
|
Risk-free interest rate reflecting the yield on the one-year Treasury bonds on grant date,
|
|
·
|
Beta calculated using one year of daily returns and comparing the risk of the individual securities to the Russell 2000 Index, and
|
|
·
|
For USEC and each of the companies in the Russell 2000 index, actual stock return from the beginning of the performance period through the grant date (January 1, 2011 – March 1, 2011) has been incorporated in the projection of the ultimate payout.
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2011
|
2010
|
2011
|
2010
|
|||||||||||||
|
(in millions)
|
||||||||||||||||
|
Numerator:
|
||||||||||||||||
|
Net income (loss)
|
$ | (6.9 | ) | $ | 1.0 | $ | (44.7 | ) | $ | (1.5 | ) | |||||
|
Net interest expense on convertible notes and convertible preferred stock dividends (a)
|
(b)
|
- |
(b)
|
(b)
|
||||||||||||
|
Net income (loss) if-converted
|
$ | (6.9 | ) | $ | 1.0 | $ | (44.7 | ) | $ | (1.5 | ) | |||||
|
Denominator:
|
||||||||||||||||
|
Weighted average common shares
|
123.0 | 115.1 | 122.4 | 114.6 | ||||||||||||
|
Less: Weighted average unvested restricted stock
|
1.7 | 1.9 | 1.7 | 2.0 | ||||||||||||
|
Denominator for basic calculation
|
121.3 | 113.2 | 120.7 | 112.6 | ||||||||||||
|
Weighted average effect of dilutive securities:
|
||||||||||||||||
|
Stock compensation awards
|
- | 0.4 | 2.1 | 0.4 | ||||||||||||
|
Convertible notes
|
44.3 | 48.1 | 44.5 | 48.1 | ||||||||||||
|
Convertible preferred stock:
|
||||||||||||||||
|
Equivalent common shares (c)
|
25.2 | 4.7 | 17.9 | 1.6 | ||||||||||||
|
Less: share issuance limitation (d)
|
2.4 | - | - | - | ||||||||||||
|
Net allowable common shares
|
22.8 | 4.7 | 17.9 | 1.6 | ||||||||||||
|
Subtotal
|
67.1 | 53.2 | 64.5 | 50.1 | ||||||||||||
|
Less: shares excluded in a period of a net loss (e)
|
67.1 | - | 64.5 | 50.1 | ||||||||||||
|
Weighted average effect of dilutive securities
|
- | 53.2 | - | - | ||||||||||||
|
Denominator for diluted calculation
|
121.3 | 166.4 | 120.7 | 112.6 | ||||||||||||
|
Net income (loss) per share – basic
|
$ | (.06 | ) | $ | .01 | $ | (.37 | ) | $ | (.01 | ) | |||||
|
Net income (loss) per share – diluted
|
$ | (.06 | ) | $ | .01 | $ | (.37 | ) | $ | (.01 | ) | |||||
|
(a)
|
Interest expense on convertible notes and convertible preferred stock dividends net of amount capitalized and net of tax.
|
|
(b)
|
No dilutive effect is recognized in a period in which a net loss has occurred. In addition, there was no net interest expense in the three and nine months ended September 30, 2011. In the nine months ended September 30, 2010, net interest expense on convertible notes and convertible preferred stock dividends was less than $0.1 million.
|
|
(c)
|
The number of equivalent common shares is based on the arithmetic average of the daily volume weighted average prices per share of common stock for each of the last 20 trading days, and is determined as of the beginning of the period for purposes of calculating diluted earnings per share.
|
|
(d)
|
Prior to obtaining shareholder approval, the preferred stock may not be converted into an aggregate number of shares of common stock in excess of 19.99% of the shares of our common stock outstanding on May 25, 2010 (approximately 22.8 million shares), in compliance with the rules of the New York Stock Exchange. If a share issuance limitation were to exist at the time of share conversion, any preferred stock shares subject to the share issuance limitation would be subject to optional or mandatory redemption for, at USEC's option, cash or SWU consideration.
|
|
(e)
|
No dilutive effect is recognized in a period in which a net loss has occurred.
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||
|
2011
|
2010
|
2011
|
2010
|
|
|
Options excluded from diluted earnings per share
|
3.1
|
2.6
|
3.1
|
2.6
|
|
Warrants excluded from diluted earnings per share
|
6.3
|
6.3
|
6.3
|
6.3
|
|
Exercise price of excluded options
|
$3.72 to
|
$5.18 to
|
$3.72 to
|
$5.18 to
|
|
$14.28
|
$16.90
|
$14.28
|
$16.90
|
|
|
Exercise price of excluded warrants
|
$7.50
|
$7.50
|
$7.50
|
$7.50
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2011
|
2010
|
2011
|
2010
|
|||||||||||||
|
(millions)
|
||||||||||||||||
|
Revenue
|
||||||||||||||||
|
LEU segment:
|
||||||||||||||||
|
Separative work units
|
$ | 297.9 | $ | 404.2 | $ | 936.7 | $ | 1,001.8 | ||||||||
|
Uranium
|
21.3 | 79.3 | 103.1 | 164.5 | ||||||||||||
| 319.2 | 483.5 | 1,039.8 | 1,166.3 | |||||||||||||
|
Contract services segment
|
55.3 | 81.1 | 169.6 | 202.7 | ||||||||||||
| $ | 374.5 | $ | 564.6 | $ | 1,209.4 | $ | 1,369.0 | |||||||||
|
Segment Gross Profit
|
||||||||||||||||
|
LEU segment
|
$ | 20.7 | $ | 32.1 | $ | 65.5 | $ | 89.1 | ||||||||
|
Contract services segment
|
6.2 | 5.9 | 8.5 | 19.7 | ||||||||||||
|
Gross profit
|
26.9 | 38.0 | 74.0 | 108.8 | ||||||||||||
|
Advanced technology costs
|
26.0 | 28.6 | 86.2 | 80.3 | ||||||||||||
|
Selling, general and administrative
|
15.6 | 14.0 | 47.8 | 43.4 | ||||||||||||
|
Other (income)
|
- | (12.4 | ) | (3.7 | ) | (32.4 | ) | |||||||||
|
Operating income (loss)
|
(14.7 | ) | 7.8 | (56.3 | ) | 17.5 | ||||||||||
|
Interest expense (income) and issuance costs, net
|
0.1 | 4.9 | (0.1 | ) | 4.8 | |||||||||||
|
Income (loss) before income taxes
|
$ | (14.8 | ) | $ | 2.9 | $ | (56.2 | ) | $ | 12.7 | ||||||
|
·
|
supply LEU to both domestic and international utilities for use in about 150 nuclear reactors worldwide;
|
|
·
|
enrich uranium at the Paducah gaseous diffusion plant (“GDP”) that we lease from the U.S. Department of Energy (“DOE”);
|
|
·
|
are the exclusive executive agent for the U.S. government under a nuclear nonproliferation program with Russia, known as Megatons to Megawatts;
|
|
·
|
are working to deploy what we believe is the world’s most advanced uranium enrichment technology, known as the American Centrifuge;
|
|
·
|
perform contract work for DOE and its contractors at the Paducah and Portsmouth sites; and
|
|
·
|
provide transportation and storage systems for spent nuclear fuel and provide nuclear and energy consulting services.
|
|
·
|
sales of the SWU component of LEU,
|
|
·
|
sales of both the SWU and uranium components of LEU, and
|
|
·
|
sales of uranium.
|
|
September 30,
|
December 31,
|
September 30,
|
||||||||||
|
2011
|
2010
|
2010
|
||||||||||
|
Long-term SWU price indicator ($/SWU)
|
$ | 155.00 | $ | 158.00 | $ | 160.00 | ||||||
|
UF
6
:
|
||||||||||||
|
Long-term price composite ($/KgU)
|
181.36 | 190.07 | 175.00 | |||||||||
|
Spot price indicator ($/KgU)
|
144.00 | 173.00 | 135.00 | |||||||||
|
No. of Employees
|
|||||||||
|
Location
|
Sept. 30,
2011
|
Dec. 31,
2010
|
|||||||
|
Paducah GDP
|
Paducah, KY
|
1,192 | 1,185 | ||||||
|
Portsmouth site
|
Piketon, OH
|
118 | 1,157 | ||||||
|
American Centrifuge
|
Primarily Oak Ridge, TN and Piketon, OH
|
443 | 453 | ||||||
|
NAC
|
Primarily Norcross, GA
|
68 | 60 | ||||||
|
Headquarters
|
Bethesda, MD
|
96 | 94 | ||||||
|
Total Employees
|
1,917 | 2,949 | |||||||
|
Nine Months
Ended September 30,
|
Cumulative
as of
September 30,
|
|||||||||||
|
2011
|
2010
|
2011
|
||||||||||
|
Amount expensed
(A)
|
$ | 85.1 | $ | 78.6 | $ | 852.5 | ||||||
|
Amount capitalized
(B
)
|
107.4 | 91.4 | 1,285.6 | |||||||||
|
Total ACP expenditures, including accruals
(C)
|
$ | 192.5 | $ | 170.0 | $ | 2,138.1 | ||||||
|
(A)
Expense included as part of Advanced Technology Costs.
|
||||||||||||
|
(B)
Amounts capitalized as part of property, plant and equipment (primarily as part of construction work in progress) total $1,252.5 million as of September 30, 2011, including capitalized interest of $112.3 million. Prepayments to suppliers under existing agreements for materials and services not yet provided totaled $33.1 million as of September 30, 2011.
|
||||||||||||
|
(C)
Total ACP expenditures are all American Centrifuge costs including, but not limited to, demonstration facility, licensing activities, commercial plant facility, program management, interest related costs and accrued asset retirement obligations capitalized. This includes $7.6 million of accruals at September 30, 2011.
|
||||||||||||
|
Three Months Ended September 30,
|
||||||||||||||||
|
2011
|
2010
|
Change
|
%
|
|||||||||||||
|
LEU segment
|
||||||||||||||||
|
Revenue:
|
||||||||||||||||
|
SWU revenue
|
$ | 297.9 | $ | 404.2 | $ | (106.3 | ) | (26 | )% | |||||||
|
Uranium revenue
|
21.3 | 79.3 | (58.0 | ) | (73 | )% | ||||||||||
|
Total
|
319.2 | 483.5 | (164.3 | ) | (34 | )% | ||||||||||
|
Cost of sales
|
298.5 | 451.4 | 152.9 | 34 | % | |||||||||||
|
Gross profit
|
$ | 20.7 | $ | 32.1 | $ | (11.4 | ) | (36 | )% | |||||||
|
Contract services segment
|
||||||||||||||||
|
Revenue
|
$ | 55.3 | $ | 81.1 | $ | (25.8 | ) | (32 | )% | |||||||
|
Cost of sales
|
49.1 | 75.2 | 26.1 | 35 | % | |||||||||||
|
Gross profit
|
$ | 6.2 | $ | 5.9 | $ | 0.3 | 5 | % | ||||||||
|
Total
|
||||||||||||||||
|
Revenue
|
$ | 374.5 | $ | 564.6 | $ | (190.1 | ) | (34 | )% | |||||||
|
Cost of sales
|
347.6 | 526.6 | 179.0 | 34 | % | |||||||||||
|
Gross profit
|
$ | 26.9 | $ | 38.0 | $ | (11.1 | ) | (29 | )% | |||||||
|
Nine Months Ended
September 30,
|
||||||||||||||||
|
2011
|
2010
|
Change
|
%
|
|||||||||||||
|
LEU segment
|
||||||||||||||||
|
Revenue:
|
||||||||||||||||
|
SWU revenue
|
$ | 936.7 | $ | 1,001.8 | $ | (65.1 | ) | (6 | )% | |||||||
|
Uranium revenue
|
103.1 | 164.5 | (61.4 | ) | (37 | )% | ||||||||||
|
Total
|
1,039.8 | 1,166.3 | (126.5 | ) | (11 | )% | ||||||||||
|
Cost of sales
|
974.3 | 1,077.2 | 102.9 | 10 | % | |||||||||||
|
Gross profit
|
$ | 65.5 | $ | 89.1 | $ | (23.6 | ) | (26 | )% | |||||||
|
Contract services segment
|
||||||||||||||||
|
Revenue
|
$ | 169.6 | $ | 202.7 | $ | (33.1 | ) | (16 | )% | |||||||
|
Cost of sales
|
161.1 | 183.0 | 21.9 | 12 | % | |||||||||||
|
Gross profit
|
$ | 8.5 | $ | 19.7 | $ | (11.2 | ) | (57 | )% | |||||||
|
Total
|
||||||||||||||||
|
Revenue
|
$ | 1,209.4 | $ | 1,369.0 | $ | (159.6 | ) | (12 | )% | |||||||
|
Cost of sales
|
1,135.4 | 1,260.2 | 124.8 | 10 | % | |||||||||||
|
Gross profit
|
$ | 74.0 | $ | 108.8 | $ | (34.8 | ) | (32 | )% | |||||||
|
Three Months Ended
September 30,
|
||||||||||||||||
|
2011
|
2010
|
Change
|
%
|
|||||||||||||
|
Gross profit
|
$ | 26.9 | $ | 38.0 | $ | (11.1 | ) | (29 | )% | |||||||
|
Advanced technology costs
|
26.0 | 28.6 | 2.6 | 9 | % | |||||||||||
|
Selling, general and administrative
|
15.6 | 14.0 | (1.6 | ) | (11 | )% | ||||||||||
|
Other (income)
|
- | (12.4 | ) | ( 12.4 | ) | (100 | )% | |||||||||
|
Operating income (loss)
|
(14.7 | ) | 7.8 | (22.5 | ) | (288 | )% | |||||||||
|
Preferred stock issuance costs
|
- | 4.8 | 4.8 | 100 | % | |||||||||||
|
Interest expense
|
0.2 | 0.3 | 0.1 | 33 | % | |||||||||||
|
Interest (income)
|
(0.1 | ) | (0.2 | ) | (0.1 | ) | (50 | )% | ||||||||
|
Income (loss) before income taxes
|
(14.8 | ) | 2.9 | (17.7 | ) | (610 | )% | |||||||||
|
Provision (benefit) for income taxes
|
(7.9 | ) | 1.9 | 9.8 | 516 | % | ||||||||||
|
Net income (loss)
|
$ | (6.9 | ) | $ | 1.0 | $ | (7.9 | ) | (790 | )% | ||||||
|
Nine Months Ended
September 30,
|
||||||||||||||||
|
2011
|
2010
|
Change
|
%
|
|||||||||||||
|
Gross profit
|
$ | 74.0 | $ | 108.8 | $ | (34.8 | ) | (32 | )% | |||||||
|
Advanced technology costs
|
86.2 | 80.3 | (5.9 | ) | (7 | )% | ||||||||||
|
Selling, general and administrative
|
47.8 | 43.4 | (4.4 | ) | (10 | )% | ||||||||||
|
Other (income)
|
(3.7 | ) | (32.4 | ) | (28.7 | ) | (89 | )% | ||||||||
|
Operating income (loss)
|
(56.3 | ) | 17.5 | (73.8 | ) | (422 | )% | |||||||||
|
Preferred stock issuance costs
|
- | 4.8 | 4.8 | 100 | % | |||||||||||
|
Interest expense
|
0.3 | 0.4 | 0.1 | 25 | % | |||||||||||
|
Interest (income)
|
(0.4 | ) | (0.4 | ) |
_-
|
_-
|
||||||||||
|
Income (loss) before income taxes
|
(56.2 | ) | 12.7 | (68.9 | ) | (543 | )% | |||||||||
|
Provision (benefit) for income taxes
|
(11.5 | ) | 14.2 | 25.7 | 181 | % | ||||||||||
|
Net (loss)
|
$ | (44.7 | ) | $ | (1.5 | ) | $ | (43.2 | ) | (2880 | )% | |||||
|
·
|
Changes to the electric power fuel cost adjustment;
|
|
·
|
Actions by DOE regarding financing of the American Centrifuge and supporting its continued development, including the potential for any cooperative agreement;
|
|
·
|
Ongoing review and evaluation of the value of capitalized costs that are part of ACP construction that could be charged to expense; and
|
|
·
|
The timing of recognition of previously deferred revenue.
|
|
Nine Months Ended
September 30,
|
||||||||
|
2011
|
2010
|
|||||||
|
Net Cash Provided by Operating Activities
|
$ | 107.2 | $ | 30.0 | ||||
|
Net Cash (Used in) Investing Activities
|
(133.9 | ) | (74.9 | ) | ||||
|
Net Cash Provided by (Used in) Financing Activities
|
(6.4 | ) | 59.7 | |||||
|
Net Increase (Decrease) in Cash and Cash Equivalents
|
$ | (33.1 | ) | $ | 14.8 | |||
|
September 30,
|
December 31,
|
|||||||
|
2011
|
2010
|
|||||||
|
(millions)
|
||||||||
|
Cash and cash equivalents
|
$ | 117.9 | $ | 151.0 | ||||
|
Accounts receivable, net
|
223.5 | 308.6 | ||||||
|
Inventories, net
|
878.3 | 806.7 | ||||||
|
Credit facility term loan, current
|
(85.0 | ) | - | |||||
|
Other current assets and liabilities, net
|
(358.1 | ) | (280.7 | ) | ||||
|
Working capital
|
$ | 776.6 | $ | 985.6 | ||||
|
·
|
the greater of (1) the JPMorgan Chase Bank prime rate (with a floor of 3%) plus 6.5%, (2) the federal funds rate plus ½ of 1% (with a floor of 3%) plus 6.5%, or (3) an adjusted 1-month LIBO Rate plus 1% (with a floor of 3%) plus 6.5%; or
|
|
·
|
the adjusted LIBO Rate (with a floor of 2%) plus 7.5%.
|
|
September 30,
|
December 31,
|
|||||||
|
2011
|
2010
|
|||||||
|
Borrowings under the revolving credit facility
|
$ | - | $ | - | ||||
|
Term loan due May 31, 2012
|
85.0 | 85.0 | ||||||
|
Letters of credit
|
16.9 | 17.3 | ||||||
|
Available credit
|
208.1 | 207.7 | ||||||
|
|
·
|
the sum of (1) the greater of a) the JPMorgan Chase Bank prime rate, b) the federal funds rate plus ½ of 1%, or c) an adjusted 1-month LIBO Rate plus 1% plus (2) a margin ranging from 2.25% to 2.75% based upon availability, or
|
|
|
·
|
the sum of the adjusted LIBO Rate plus a margin ranging from 4.0% to 4.5% based upon availability.
|
|
Requirement
|
Outcome
|
|
Availability ≥ $100 million
|
If not maintained, then the aggregate amount of spending on the American Centrifuge project (1) made in any calendar month shall not exceed $5 million and (2) made in the aggregate shall not exceed $25 million
until the 60
th
consecutive day after minimum Availability is restored
.
|
|
Previous Requirement
|
New Requirement
|
Outcome
|
|
Availability ≥ greater of 10% of aggregate lender commitments or $32.5 million
|
Availability ≥ the sum of (a) greater of (i) 10% of aggregate lender commitments or (ii) $32.5 million
plus
(b) $17.5 million
|
If not met at any time, an event of default is triggered.
|
|
Availability ≥ $75.0 million`
|
Availability ≥ $100.0 million
|
If not met at any time, fixed charge ratio required to be 1.00 to 1.00 until the 90
th
consecutive day Availability is restored.
|
|
December 31,
2010
|
Additions
|
Amortization
|
September 30,
2011
|
|||||||||||||
|
Other current assets:
|
||||||||||||||||
|
Bank credit facilities
|
$ | 7.4 | $ | 0.5 | $ | (4.1 | ) | $ | 3.8 | |||||||
|
Deferred financing costs (long-term):
|
||||||||||||||||
|
Convertible notes
|
$ | 8.1 | $ | - | $ | (2.1 | ) | $ | 6.0 | |||||||
|
ACP project
|
2.5 | 4.3 | - | 6.8 | ||||||||||||
|
Deferred financing costs
|
$ | 10.6 | $ | 4.3 | $ | (2.1 | ) | $ | 12.8 0 | |||||||
|
Financial Assurance
|
Long-Term Liability
|
|||||||||||||||
|
September 30,
2011
|
December 31,
2010
|
September 30,
2011
|
December 31,
2010
|
|||||||||||||
|
Depleted uranium disposition and stored wastes
|
$ | 223.0 | $ | 215.8 | $ | 139.7 | $ | 125.4 | ||||||||
|
Decontamination and decommissioning of American Centrifuge
|
22.2 | 22.2 | 22.6 | 22.6 | ||||||||||||
|
Other financial assurance
|
19.4 | 19.8 | ||||||||||||||
|
Total financial assurance
|
$ | 264.6 | $ | 257.8 | ||||||||||||
|
Letters of credit
|
16.9 | 17.3 | ||||||||||||||
|
Surety bonds
|
247.7 | 240.5 | ||||||||||||||
|
Cash collateral deposit for surety bonds
|
$ | 144.4 | $ | 140.8 | ||||||||||||
|
|
•
|
commodity price risk for electric power requirements for the Paducah GDP (refer to “Overview – Cost of Sales for SWU and Uranium” and “Results of Operations – Cost of Sales”),
|
|
|
•
|
interest rate risk relating to the outstanding term loan and any outstanding borrowings at variable interest rates under our credit facility (refer to “Liquidity and Capital Resources – Capital Structure and Financial Resources”), and
|
|
|
•
|
interest rate and other market risks relating to the valuation of our convertible preferred stock (refer to “Liquidity and Capital Resources – Capital Structure and Financial Resources”).
|
|
·
|
Our ability to negotiate an acceptable power arrangement with TVA or other suppliers of power;
|
|
·
|
Our success in obtaining a contract with DOE for programs such as enriching a portion of the DOE’s depleted uranium stockpile on satisfactory terms, in sufficient amount, or at all; and
|
|
·
|
SWU supply and demand and the outcome of discussions with customers about their near term SWU supply needs.
|
|
•
|
Cause us to need to continue to suspend or possibly to terminate contracts with suppliers and contractors involved in the American Centrifuge project and make it more difficult for us to maintain key suppliers for the ACP and the manufacturing infrastructure developed over the last several years;
|
|
|
•
|
Cause us to implement worker layoffs and potentially lose key skilled personnel, some of whom have security clearances, which could be difficult to re-hire or replace, and incur severance and other termination costs;
|
|
|
•
|
Delay our efforts to reduce the centrifuge machine cost through value engineering; and
|
|
|
•
|
Delay our deployment of the American Centrifuge project and increase the overall cost of the project, which could adversely affect the overall economics of the project.
|
|
·
|
November 2011 – Secure firm financing commitment(s) for the construction of the commercial American Centrifuge Plant with an annual capacity of approximately 3.5 million SWU per year;
|
|
·
|
May 2014 – begin commercial American Centrifuge Plant operations;
|
|
·
|
August 2015 – commercial American Centrifuge Plant annual capacity at 1 million SWU per year; and
|
|
·
|
September 2017 – commercial American Centrifuge Plant annual capacity of approximately 3.5 million SWU per year.
|
|
(c) Total Number
|
(d) Maximum Number
|
|||||||
|
(a) Total
|
(b)
|
of Shares (or Units)
|
(or Approximate Dollar
|
|||||
|
Number of
|
Average
|
Purchased as Part
|
Value) of Shares (or
|
|||||
|
Shares (or
|
Price Paid
|
of Publicly
|
Units) that May Yet Be
|
|||||
|
Units)
|
Per Share
|
Announced Plans
|
Purchased Under the
|
|||||
|
Period
|
Purchased(1)
|
(or Unit)
|
or Programs
|
Plans or Programs
|
||||
|
July 1 – July 31
|
7,267
|
$3.38
|
-
|
-
|
||||
|
August 1 – August 31
|
1,296
|
$2.26
|
-
|
-
|
||||
|
September 1 – September 30
|
2,078
|
$1.80
|
-
|
-
|
||||
|
Total
|
10,641
|
$2.93
|
-
|
-
|
|
(1)
|
These purchases were not made pursuant to a publicly announced repurchase plan or program. Represents 10,641 shares of common stock surrendered to USEC to pay withholding taxes on shares of restricted stock under the Company’s equity incentive plan.
|
|
|
3.1
|
Certificate of Incorporation of USEC Inc., as amended.
|
|
|
4.1
|
Tax Benefit Preservation Plan, dated as of September 29, 2011, between USEC Inc. and Mellon Investor Services LLC, which includes the Form of Certificate of Designations of Series A Junior Participating Preferred Stock as Exhibit A, the Form of Right Certificate as Exhibit B and the Summary of Rights to Purchase Preferred Shares as Exhibit C., incorporated by reference to Exhibit 4.1 of the Current Report on Form 8-K filed on September 30, 2011 (Commission file number 1-14287).
|
|
|
10.1
|
First Amendment to Standstill Agreement dated as of August 15, 2011 by and among Toshiba America Nuclear Energy Corporation, Babcock & Wilcox Investment Company and USEC Inc. incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on August 15, 2011 (Commission file number 1-14287).
|
|
|
10.2
|
Second Amendment to Standstill Agreement dated as of September 30, 2011 by and among Toshiba America Nuclear Energy Corporation, Babcock & Wilcox Investment Company and USEC Inc. incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on September 30, 2011 (Commission file number 1-14287).
|
|
|
31.1
|
Certification of the Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a).
|
|
|
31.2
|
Certification of the Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a).
|
|
|
32.1
|
Certification of CEO and CFO pursuant to 18 U.S.C. Section 1350.
|
|
|
101
|
Consolidated condensed financial statements from the quarterly report on Form 10-Q for the quarter ended September 30, 2011, furnished in interactive data file (XBRL) format.
|
|
USEC Inc.
|
|||
|
Date: November 4, 2011
|
By:
|
/s/ John C. Barpoulis
|
|
|
John C. Barpoulis
|
|||
|
Senior Vice President and Chief Financial Officer
|
|||
|
(Principal Financial Officer)
|
|||
|
3.1
|
Certificate of Incorporation of USEC Inc., as amended.
|
|
4.1
|
Tax Benefit Preservation Plan, dated as of September 29, 2011, between USEC Inc. and Mellon Investor Services LLC, which includes the Form of Certificate of Designations of Series A Junior Participating Preferred Stock as Exhibit A, the Form of Right Certificate as Exhibit B and the Summary of Rights to Purchase Preferred Shares as Exhibit C., incorporated by reference to Exhibit 4.1 of the Current Report on Form 8-K filed on September 30, 2011 (Commission file number 1-14287).
|
|
10.1
|
First Amendment to Standstill Agreement dated as of August 15, 2011 by and among Toshiba America Nuclear Energy Corporation, Babcock & Wilcox Investment Company and USEC Inc. incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on August 15, 2011 (Commission file number 1-14287).
|
|
10.2
|
Second Amendment to Standstill Agreement dated as of September 30, 2011 by and among Toshiba America Nuclear Energy Corporation, Babcock & Wilcox Investment Company and USEC Inc. incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on September 30, 2011 (Commission file number 1-14287).
|
|
31.1
|
Certification of the Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a).
|
|
31.2
|
Certification of the Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a).
|
|
32.1
|
Certification of CEO and CFO pursuant to 18 U.S.C. Section 1350.
|
|
101
|
Consolidated condensed financial statements from the quarterly report on Form 10-Q for the quarter ended September 30, 2011, furnished in interactive data file (XBRL) format.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|